The benefits of HPV vaccination
On 9 February, President Cristina Kirchner announced during the presentation of the National Institute for Tropical Medicine (In met), the incorporation of HPV vaccination at the National Immunization Schedule. During the announcement said that the decision of the National State “has to do with other measure was the creation of the National Cancer Institute, which in turn is related to the protection of gender.”
Some of these issues were revealed through the proclamation of the President, such as the age at which the new vaccine will be given to coincide with three immunizations in the CNV (Hepatitis B, MMR, and three bacterial).
Dr. Ricardo Guttmann, Coordinator of the Vaccine Infectious Diseases Society of Argentina (SADI), told this newspaper that most of the countries that have incorporated this vaccine, applied to the same population (women aged 11 years). He added that “without doubt, the measure has a very important from the standpoint of public health since cervical cancer is the second most important female cancer.” Each year in Argentina, more than 6,000 newly diagnosed cases of this disease, of which about half of these women lost their lives (between 2,500 and 3,000).
More than 99% of cervical cancer cases are linked to long-term infection with human papillomavirus high-risk. The genotypes of the virus most prevalent, not only in Argentina but also in the rest of the world, are 16 and 18 to produce, as needed Dr. Guttmann “between 70 and 75% of all cervical cancers cancer.